IONQ
IONQ
$44.77
-0.69%
IonQ is a quantum computing company that provides access to its quantum computers via cloud platforms, offering quantum-computing-as-a-service (QCaaS) to customers. As a pure-play leader in trapped-ion quantum computing, IonQ differentiates itself through its high-fidelity qubits and cloud-based delivery model, positioning it as a pioneer in the emerging quantum sector. The current investor narrative centers on the company's potential to capitalize on government funding and commercial adoption, but is tempered by ongoing losses, insider stock sales, and the need for a clear path to profitability. Recent news highlights a 40% drop from all-time highs and concerns about cash runway, making the stock a high-risk, high-reward speculative play.…
IONQ
IONQ
$44.77
Related headlines
Investment Opinion: Should I buy IONQ Today?
Rating: Hold. Thesis: IonQ is a high-risk speculative play on quantum computing with strong revenue growth but extreme valuation and no profitability, making it suitable only for aggressive investors with a high risk tolerance. The analyst consensus is bullish (3 Buy, 1 Neutral), but the average target price is not provided; however, the forward PS of ~9.7x implies significant growth expectations.
Supporting Evidence: IonQ's revenue grew 428.5% YoY in Q4 2025, but the trailing PS of 96.8x is unsustainable. Gross margin improved to 56.5% from 9.9% a year ago, showing scaling benefits. However, free cash flow is deeply negative at -$301.8M TTM, and the company has negative EPS. The forward PS of ~9.7x (based on $1.29B estimated revenue) is more reasonable but still high for a company with negative operating margins. The stock's beta of 3.23 and 31.2% monthly decline highlight extreme volatility.
Risks & Conditions: The biggest risks are valuation compression if growth slows, cash burn leading to dilution, and insider selling. This Hold would upgrade to Buy if the stock falls below $30 (near 52-week low) or if the company achieves positive free cash flow. It would downgrade to Sell if revenue growth decelerates below 50% YoY or if the company announces a dilutive equity offering. Overall, IonQ is overvalued relative to its fundamentals but fairly valued relative to its growth potential in the quantum sector.
Sign up to view all
IONQ 12-Month Price Forecast
IonQ's outlook is highly uncertain. The bull case hinges on sustained rapid revenue growth and government backing, while the bear case focuses on valuation and cash burn. The base case of 50% probability reflects a balanced view where growth continues but at a slower pace, keeping the stock range-bound. The neutral stance is justified by the extreme valuation and lack of profitability, which limit upside potential. An upgrade to bullish would require evidence of a clear path to profitability or a significant valuation correction. A downgrade to bearish would follow a revenue miss or dilutive event.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $58.20 and implied upside of +30.0% versus the current price.
Average Target
$58.20
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$36 - $58
Analyst target range
IonQ has coverage from 3 analysts, with a consensus that leans bullish based on recent ratings (Benchmark, Craig-Hallum, Needham all at Buy, Goldman Sachs at Neutral). The average analyst target price is not directly provided, but the estimated revenue consensus of $1.29 billion for the next fiscal year implies a forward PS of ~9.7x, which is a significant discount to the trailing PS. The implied upside/downside cannot be calculated without a target price, but the revenue estimates suggest analysts expect substantial growth. The high revenue estimate of $1.65 billion and low of $1.17 billion indicate a wide range of outcomes, reflecting high uncertainty. The high target assumes rapid government and commercial adoption, while the low target factors in slower growth or competitive pressures. Recent institutional ratings show no changes in 2024, with most firms maintaining Buy or Neutral stances. The limited analyst coverage (3 analysts) is typical for a small-cap, early-stage company, which can lead to higher volatility and less efficient price discovery. Investors should note that the wide spread in revenue estimates signals low conviction in near-term forecasts.
Bulls vs Bears: IONQ Investment Factors
IonQ presents a high-risk, high-reward speculative investment. The bull case rests on accelerating revenue growth (428.5% YoY), government backing providing a cash runway, and improving gross margins. However, the bear case is equally compelling: extreme valuation (trailing PS 96.8x), massive cash burn (-$301.8M FCF TTM), insider selling ($857M over two years), and high volatility (beta 3.23). The single most important tension is whether revenue growth can continue at a pace that justifies the current valuation—if growth decelerates, the stock could see severe multiple compression. Currently, the bear case has stronger evidence due to the unsustainable valuation and lack of profitability, but the bull case could prevail if government contracts accelerate commercial adoption.
Bullish
- Revenue Growth Accelerating: Q4 2025 revenue surged 428.5% YoY to $61.89M, and full-year 2025 revenue reached $130.1M, up from $43.1M in 2024. This rapid growth is driven by larger contracts and government funding, signaling strong commercial adoption.
- Government Backing Provides Runway: The U.S. government's shift to direct equity ownership in quantum computing provides a sovereign-backed capital runway. IonQ holds $1.04B in cash with minimal debt (debt-to-equity 0.008), ensuring liquidity to fund operations through 2028.
- Gross Margin Improvement: Gross margin improved from 9.9% in Q4 2024 to 56.5% in Q4 2025, indicating scaling benefits as revenue grows. This trend suggests potential for operating leverage as the company matures.
- Analyst Consensus Bullish: Of 3 analysts covering IonQ, 3 rate it Buy (Benchmark, Craig-Hallum, Needham) and 1 Neutral (Goldman Sachs). The average revenue estimate of $1.29B for next fiscal year implies a forward PS of ~9.7x, a significant discount to the trailing PS of 96.8x.
Bearish
- Extreme Valuation Premium: Trailing PS ratio of 96.8x and EV/Sales of 87.4x are astronomically high compared to any traditional tech company. Even the forward PS of ~9.7x is elevated for a company with negative earnings and operating margin of -392%.
- Massive Cash Burn: Free cash flow was -$83.3M in Q4 2025 and -$301.8M TTM. Operating losses persist, with operating income of -$242.7M in Q4 2025. At this burn rate, the $1.04B cash pile provides about 3.4 years of runway, but dilution risk is high.
- Insider Selling Red Flag: Insiders at leading quantum computing companies have sold $857M in stock over two years with virtually no buying. This signals a major red flag for retail investors, as insiders may be cashing out before a potential downturn.
- High Volatility and Momentum Reversal: Beta of 3.23 makes IonQ over 3x more volatile than the S&P 500. The stock dropped 31.2% in the past month and is down 40% from its all-time high of $84.64, indicating a sharp reversal of the prior uptrend.
IONQ Technical Analysis
IonQ's 1-year price change of +9.77% masks significant volatility, with the stock currently trading at $49.12, approximately 58% of its 52-week range (low $25.89, high $84.64). This positioning near the lower end of the range suggests a pullback from prior highs, potentially offering a value entry if the downtrend reverses, but also reflecting waning momentum. The stock's beta of 3.23 indicates it is over three times more volatile than the S&P 500, amplifying both upside and downside risks. Over the past 3 months, IonQ surged 67.65%, but the 1-month change of -31.20% shows a sharp reversal, indicating a loss of short-term momentum. This divergence between the strong 3-month gain and the recent 1-month decline suggests a potential trend reversal or a temporary pullback within a broader uptrend. The relative strength versus the S&P 500 over 1 month is -29.95%, underperforming the market significantly. The 52-week low of $25.89 serves as key support, while the 52-week high of $84.64 is major resistance. A break below $25.89 would signal a breakdown and potential further downside, while a move above $84.64 would indicate a resumption of the long-term uptrend. Given the high beta, position sizing should account for amplified swings, and the recent sharp decline from the May highs near $72 suggests increased downside risk in the near term.
Beta
3.23
3.23x market volatility
Max Drawdown
-67.6%
Largest decline past year
52-Week Range
$26-$85
Price range past year
Annual Return
-1.7%
Cumulative gain past year
| Period | IONQ Return | S&P 500 |
|---|---|---|
| 1m | -21.0% | +2.0% |
| 3m | +55.5% | +10.6% |
| 6m | -9.5% | +8.3% |
| 1y | -1.7% | +20.4% |
| ytd | -4.3% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IONQ Fundamental Analysis
IonQ's revenue trajectory shows strong growth, with Q4 2025 revenue of $61.89 million, up 428.5% year-over-year from $11.71 million in Q4 2024. However, this growth is lumpy, as Q3 2025 revenue was $39.87 million and Q2 2025 was $20.69 million, indicating quarter-to-quarter variability. The full-year 2025 revenue of $130.1 million (sum of quarters) represents a significant acceleration from 2024's $43.1 million, driven by larger contracts and government funding. The company remains unprofitable, with a net loss of $703.5 million in Q4 2025, though this includes a large non-cash gain from a change in fair value of warrant liabilities. Excluding that, operating losses persist, with operating income of -$242.7 million in Q4 2025. Gross margin improved to 56.5% in Q4 2025 from 9.9% in Q4 2024, indicating scaling benefits, but operating margin remains deeply negative at -392%. The net margin for Q4 2025 was 11.4% due to the one-time gain, but normalized margins are deeply negative. IonQ has a strong balance sheet with $1.04 billion in cash as of Q4 2025, minimal debt (debt-to-equity of 0.008), and a current ratio of 15.5, providing ample liquidity. However, free cash flow was negative -$83.3 million in Q4 2025 and -$301.8 million for the trailing twelve months, meaning the company is burning cash to fund operations. The reliance on equity financing (common stock issued of $1.95 billion in 2025) highlights dilution risk, though the government's equity backing provides a cushion. ROE was 18.5% in Q4 2025, inflated by the one-time gain, but historically negative.
Quarterly Revenue
$61890000.0B
2025-12
Revenue YoY Growth
+428.52%
YoY Comparison
Gross Margin
56.48%
Latest Quarter
Free Cash Flow
$-301797000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IONQ Overvalued?
Given IonQ's negative net income (EPS of -$0.04 in the latest quarter), the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 96.8x, while the forward PS ratio is not directly provided but can be estimated using estimated revenue of $1.29 billion (analyst consensus) and market cap of $12.58 billion, yielding a forward PS of ~9.7x. The massive gap between trailing and forward PS reflects expectations of rapid revenue growth. Compared to the industry average PS ratio (not provided), IonQ trades at a significant premium to any traditional hardware or software company, but this is typical for early-stage quantum computing firms. The EV/Sales ratio of 87.4x further underscores the extreme valuation. Historically, IonQ's PS ratio has ranged from 1281x in early 2022 to 96.8x currently, indicating a massive compression as revenue has grown. The current PS is near the lower end of its historical range, suggesting that the market has tempered its growth expectations, but the absolute level remains extremely high. The PEG ratio of -1.48 is not meaningful due to negative earnings. Overall, the valuation reflects a high-growth, high-risk profile where investors are pricing in substantial future revenue, but any miss on growth could lead to multiple compression.
PE
-24.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -148x~6x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-24.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IonQ's primary financial risk is its extreme cash burn rate. With free cash flow of -$301.8M TTM and operating losses of -$242.7M in Q4 2025, the company is consuming cash rapidly. Although it has $1.04B in cash, the burn rate implies a runway of about 3.4 years, and the company may need to raise additional capital through equity offerings, causing dilution. The net margin of -392.6% (operating) highlights the lack of profitability. Revenue concentration is also a risk, as Q4 2025 revenue of $61.89M was lumpy and dependent on large government contracts, which may not be repeatable.
Market & Competitive Risks: The stock trades at a trailing PS of 96.8x, which is extremely high relative to any traditional tech peer. This valuation leaves little room for error—any revenue miss could trigger a sharp multiple contraction. The quantum computing sector is highly competitive, with well-funded players like IBM, Google, and Quantinuum (recent IPO) potentially cannibalizing IonQ's market share. The stock's beta of 3.23 indicates high sensitivity to market downturns, and the recent 31.2% monthly decline shows momentum can reverse violently. Regulatory risks include potential changes in government funding priorities, as the sector relies heavily on federal support.
Worst-Case Scenario: In a worst-case scenario, revenue growth decelerates sharply due to contract delays or competitive losses, leading to a loss of investor confidence. The stock could fall to its 52-week low of $25.89, representing a -47.3% decline from the current price of $49.12. If the company needs to raise capital at depressed prices, dilution could further pressure the stock. Historical max drawdown of -67.6% suggests that in a severe downturn, the stock could fall to around $16, a -67% loss from current levels.
FAQ
The key risks are: 1) Valuation risk: Trailing PS of 96.8x leaves no room for error; a revenue miss could trigger a sharp decline. 2) Cash burn risk: Free cash flow of -$301.8M TTM could force dilutive equity offerings. 3) Competitive risk: Well-funded players like IBM, Google, and Quantinuum could capture market share. 4) Insider selling risk: Insiders have sold $857M in stock over two years, signaling a lack of confidence. The most severe risk is a 47% decline to the 52-week low of $25.89 if growth disappoints.
The 12-month outlook is uncertain, with three scenarios: Bull case (25% probability) targets $65-$85, driven by accelerated government contracts and gross margin expansion. Base case (50% probability) targets $40-$60, assuming 100-150% revenue growth and stable margins. Bear case (25% probability) targets $25-$40, if growth disappoints or dilution occurs. The base case is most likely, reflecting balanced risk/reward. The AI assessment is neutral with medium confidence, citing the extreme valuation and cash burn as key concerns.
IonQ is overvalued based on traditional metrics, with a trailing PS of 96.8x and EV/Sales of 87.4x, which are extremely high compared to any profitable tech company. However, the forward PS of ~9.7x (based on estimated revenue of $1.29B) is more reasonable and reflects the market's expectation of rapid growth. Historically, the PS ratio has compressed from 1281x in early 2022 to 96.8x currently, indicating that the market has tempered expectations. The stock is priced for perfection, meaning any growth disappointment could lead to severe multiple compression. Overall, it is overvalued relative to fundamentals but fairly valued relative to its growth potential in the quantum sector.
IonQ is a high-risk, high-reward speculative stock. The company has strong revenue growth (428.5% YoY in Q4 2025) and government backing, but it trades at an extreme trailing PS of 96.8x and is unprofitable with negative free cash flow of -$301.8M TTM. The analyst consensus is bullish (3 Buy, 1 Neutral), but the stock's beta of 3.23 and 31.2% monthly decline indicate high volatility. It could be a good buy for aggressive investors with a long-term horizon who believe in quantum computing, but it is not suitable for risk-averse investors. The biggest downside risk is a 47% decline to the 52-week low of $25.89.
IonQ is more suitable for long-term investment (5+ years) due to its speculative nature and high volatility (beta 3.23). Short-term trading is risky given the 31.2% monthly decline and potential for sharp reversals. The company is in an early growth stage with no dividends (yield 0%) and negative earnings, so it is not suitable for income investors. Long-term investors should be prepared for significant drawdowns (historical max drawdown -67.6%) and should only invest capital they can afford to lose. A minimum holding period of 5 years is recommended to allow the quantum computing thesis to play out.